Cubist Systematic Strategies’s LifeMD LFMD Stock Holding History

Cubist Systematic Strategies’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-44,900	Closed	-$612K	–	3294
2025 Q2	$612K	Buy	+44,900	New	+$424K	﹤0.01%	2170

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's LFMD Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of LifeMD (LFMD) in Q2 2025, closing a stake of 13,332 shares — an estimated $126K sold.

Cubist Systematic Strategies first reported a position in LFMD in Q4 2023 and held it in 6 quarters. The position peaked at $4.93M in Q1 2024. 128 funds tracked by Wall St. Rank hold LFMD as of Q2 2025.

Cubist Systematic Strategies reported no remaining LifeMD position as of Q2 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 13,332 LifeMD shares in Q2 2025, an estimated $126K.
Cubist Systematic Strategies first reported a position in LifeMD in Q4 2023 and held it in 6 quarters.
Cubist Systematic Strategies's LifeMD position peaked at $4.93M in Q1 2024.
128 funds tracked by Wall St. Rank held LifeMD as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.